CTRI/2024/03/064161
Not yet recruiting
Phase 4
Comparative study to evaluate efficacy and safety of topical alcaftadine 0.25% versus topical olopatadine 0.2% eye drops in patients with allergic conjunctivits in a tertiary care teaching hospital, Haldwani - NI
eeraj Rajdan0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: H109- Unspecified conjunctivitis
- Sponsor
- eeraj Rajdan
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient aged 5\-20 years of age with history of allergic conjunctivitis presenting to OPD will be enrolled
Exclusion Criteria
- •Subjects undergone any ocular surgical intervention within three months
- •Patients on steroid therapy, immunotherapeutic agents
- •Patients using other topical eye drops (ocular lubricants)
- •Patients used any investigational medication within one month of the study
- •Patients with known hypersensitivity to Olopatadine \& Alcaftadine
- •Pregnant and lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Comparison of dexmedetomidine and clonidine in caudal block in paediatric patients posted for infra umbilical surgeries.Health Condition 1: N399- Disorder of urinary system, unspecifiedCTRI/2024/01/061191Acharya Vinobha Bhave Rural Hospital
Not yet recruiting
Phase 4
Comparison of adhesive and suture in skin closure following small incision abdominal surgery(laparoscopic)CTRI/2024/07/070591Adichunchanagiri Institute Of Medical Sciences
Completed
Phase 4
A comparative study between Whitfields ointment + Oral fluconazole Vs 1% butenafine in tinea infections of skiHealth Condition 1: null- Tinea infections of skinCTRI/2012/08/002914Department of Pharmacology and Department of Skin and VD CU Shah Medical College and Hospital120
Completed
Phase 4
A comparative study between 2% Sertaconazole vs topical 1% Butenafine in tinea infections of skiHealth Condition 1: null- Tinea infections of skinCTRI/2012/06/002714Department of Pharmacology and Department of Skin and VD CU Shah Medical College and Hospital125
Recruiting
Phase 2
evaluation the effect of botulinum toxin type A for treating frown linesskin rejuvenation.IRCT20150101020514N8Imen vaccine alborz Company140